World journal of surgery · 2026
Safety and Feasibility of Early Laparoscopic Cholecystectomy in High-Risk Acute Cholecystitis: A Critical Evaluation of Tokyo Guidelines 2018 Risk Stratification.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miyoshi Yuya, Hashida Shinsuke, Ohki Masayoshi, Yamamoto Sumiharu, Ikeda Hirokuni, Hayashi Nobuyasu, Tsukuda Kazunori
Аннотация
AIM: This study evaluated the safety and appropriateness of early laparoscopic cholecystectomy (LapC) for acute cholecystitis classified as high-risk according to the Tokyo Guidelines 2018 (TG18).
METHODS: We retrospectively analyzed 126 patients who underwent early LapC between January 2023 and August 2024. Patients were classified into high-risk (n = 67) and low-risk (n = 59) groups based on TG18 criteria. Primary endpoints were in-hospital mortality and major complications (Clavien-Dindo ≥ IIIa).
RESULTS: No in-hospital mortality occurred. Major complications were observed in seven patients (5.6%) with no significant difference between groups (6.0% vs. 5.1%, p = 0.467). Grade 3 cholecystitis was independently associated with overall complications (adjusted OR 3.12, 95% CI 1.03-21.47, p = 0.046). Among Grade 1-2 cases, neither age-adjusted Charlson Comorbidity Index (AA-CCI) nor American Society of Anesthesiologists Physical Status (ASA-PS) correlated with complications, whereas higher preoperative C-reactive protein was an independent predictor (adjusted OR 1.05, 95% CI 1.00-1.10, p = 0.037).
CONCLUSION: In our single-center experience, early LapC was safely performed in TG18-defined high-risk patients with Grade 1-2 cholecystitis. Traditional static risk indicators (AA-CCI, ASA-PS) showed limited predictive value in our cohort, whereas dynamic inflammatory markers such as CRP showed potential for risk assessment, though further validation is needed.
METHODS: We retrospectively analyzed 126 patients who underwent early LapC between January 2023 and August 2024. Patients were classified into high-risk (n = 67) and low-risk (n = 59) groups based on TG18 criteria. Primary endpoints were in-hospital mortality and major complications (Clavien-Dindo ≥ IIIa).
RESULTS: No in-hospital mortality occurred. Major complications were observed in seven patients (5.6%) with no significant difference between groups (6.0% vs. 5.1%, p = 0.467). Grade 3 cholecystitis was independently associated with overall complications (adjusted OR 3.12, 95% CI 1.03-21.47, p = 0.046). Among Grade 1-2 cases, neither age-adjusted Charlson Comorbidity Index (AA-CCI) nor American Society of Anesthesiologists Physical Status (ASA-PS) correlated with complications, whereas higher preoperative C-reactive protein was an independent predictor (adjusted OR 1.05, 95% CI 1.00-1.10, p = 0.037).
CONCLUSION: In our single-center experience, early LapC was safely performed in TG18-defined high-risk patients with Grade 1-2 cholecystitis. Traditional static risk indicators (AA-CCI, ASA-PS) showed limited predictive value in our cohort, whereas dynamic inflammatory markers such as CRP showed potential for risk assessment, though further validation is needed.